Athersys, Inc.
(NASDAQ : ATHX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.96%724.852.6%$747.47m
AMGNAmgen, Inc. 0.13%231.241.4%$609.30m
BIIBBiogen, Inc. -0.74%260.321.8%$575.75m
MRNAModerna, Inc. -3.60%120.640.0%$568.68m
GILDGilead Sciences, Inc. -0.11%64.881.0%$549.46m
VRTXVertex Pharmaceuticals, Inc. -0.08%298.381.9%$429.56m
ILMNIllumina, Inc. -1.94%208.593.2%$402.86m
SNSSSunesis Pharmaceuticals, Inc. 0.75%4.050.7%$283.11m
SAVACassava Sciences, Inc. -5.17%40.160.0%$179.87m
BNTXBioNTech SE -0.68%136.590.0%$108.65m
TECHBio-Techne Corp. -4.14%296.284.5%$96.60m
BMRNBioMarin Pharmaceutical, Inc. -3.14%88.614.2%$92.91m
PRTAProthena Corp. Plc -2.55%57.0813.8%$77.20m
CRSPCRISPR Therapeutics AG -4.04%62.630.6%$75.07m
NVAXNovavax, Inc. -8.16%16.6175.6%$73.03m

Company Profile

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.